Related Experiment Video
Updated: Oct 13, 2025

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Published on: April 15, 2017
TSSF-hERG: A machine-learning-based hERG potassium channel-specific scoring function for chemical cardiotoxicity
Jinhui Meng1, Li Zhang2, Lianxin Wang1
1School of Life Science, Liaoning University, Shenyang, 110036, China.
A new computational model, TSSF-hERG, accurately predicts drug binding affinity to the hERG channel. This tool aids in identifying cardiotoxicity risks early, reducing drug development costs and time.
Area of Science:
- Computational chemistry
- Pharmacology
- Cardiovascular research
Background:
- The human ether-à-go-go-related gene (hERG) channel is crucial for cardiomyocyte repolarization.
- hERG channel blockers can cause cardiotoxicity, leading to drug candidate disqualification.
- In silico prediction of drug-hERG binding affinity can accelerate drug discovery.
Purpose of the Study:
- To develop and validate a machine learning model for predicting drug binding affinity to the hERG channel.
- To improve the accuracy of in silico cardiotoxicity assessments.
- To reduce the time and cost associated with experimental drug screening.
Main Methods:
- Collected 9,215 compounds with AutoDock Vina docking structures for training.
- Utilized five machine learning algorithms combined with ligand and interaction features.
- Employed tenfold cross-validation and external verification for model assessment.
Main Results:
- The Support Vector Regression (SVR) model, TSSF-hERG, demonstrated superior performance.
- TSSF-hERG achieved a Pearson's correlation coefficient (Rp) of 0.765 and Spearman's rank correlation coefficient (Rs) of 0.757.
- The model outperformed AutoDock Vina's scoring function and RF-Score.
Conclusions:
- TSSF-hERG significantly enhances the prediction of drug-hERG binding affinity.
- The model can be utilized for virtual screening of drug candidates to predict hERG-related cardiotoxicity.
- This approach aids in the early identification of potential cardiotoxic compounds in drug development.
More Related Videos
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022